Evidence for disease-regulated transgene expression in the brain with use of lentiviral vectors

Journal of Neuroscience Research

Volumn 84, Issue 1, 2006, Pages 58-67

  Jakobsson, Johan ^a   Rosenqvist, Nina ^a   Mårild, Karl ^a   Agoston, Denes V ^b   Lundberg, Cecilia ^a  

^a LUND UNIVERSITY   (Sweden)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

Brain; Disease regulated transgene expression; Lentiviral vectors

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; LENTIVIRUS VECTOR; OXIDOPAMINE; PREPROENKEPHALIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; BRAIN DAMAGE; CONTROLLED STUDY; DISEASE SEVERITY; EVIDENCE BASED MEDICINE; EXCITOTOXICITY; GENE CONTROL; GENE EXPRESSION; GENE OVEREXPRESSION; GENE TARGETING; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RAT; REMISSION; TRANSGENE; UPREGULATION; VALIDATION STUDY;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; BETA-GALACTOSIDASE; BRAIN; BRAIN INJURIES; FUNCTIONAL LATERALITY; GENE EXPRESSION REGULATION; GENETIC VECTORS; GLIAL FIBRILLARY ACIDIC PROTEIN; GREEN FLUORESCENT PROTEINS; HUMANS; IBOTENIC ACID; IMMUNOHISTOCHEMISTRY; LENTIVIRUS; NERVE TISSUE PROTEINS; OXIDOPAMINE; PROMOTER REGIONS (GENETICS); RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS;

EID: 33745785622     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.20872     Document Type: Article

References (35)

1. Agoston DV, Dobi A. 2000. Complexity of transcriptional control in neuropeptide gene expression; enkephalin gene regulation during neurodevelopment. Biochem Soc Trans 28:446-451.
2. Azzouz M, Kingsman SM, Mazarakis ND. 2004. Lentiviral vectors for treating and modeling human CNS disorders. J Gene Med 6:951-962.
3. Bjorklund A, Stenevi U, Schmidt RH, Dunnett SB, Gage FH. 1983. Intracerebral grafting of neuronal cell suspensions. I. Introduction and general methods of preparation. Acta Physiol Scand Suppl 522:1-7.
4. Blomer U, Naldini L, Kafri T, Trono D, Verma IM, Gage FH. 1997. Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector. J Virol 71:6641-6649.
5. Borsook D, Rosen H, Collard M, Dressler H, Herrup K, Comb MJ, Hyman SE. 1992. Expression and regulation of a proenkephalin beta-galactosidase fusion gene in the reproductive system of transgenic mice. Mol Endocrinol 6:1502-1512.
6. Brenner M, Kisseberth WC, Su Y, Besnard F, Messing A. 1994. GFAP promoter directs astrocyte-specific expression in transgenic mice. J Neurosci 14:1030-1037.
7. Capone G, Choi C, Vertifuille J. 1998. Regulation of the preprosomatostatin gene by cyclic-AMP in cerebrocortical neurons. Brain Res Mol Brain Res 60:247-258.
8. Cenci MA, Campbell K, Bjorklund A. 1993. Neuropeptide messenger RNA expression in the 6-hydroxydopamine-lesioned rat striatum reinnervated by fetal dopaminergic transplants: differential effects of the grafts on preproenkephalin, preprotachykinin and prodynorphin messenger RNA levels. Neuroscience 57:275-296.
9. Comb MJ, Kobierski L, Chu HM, Tan Y, Borsook D, Herrup K, Hyman SE. 1992. Regulation of opioid gene expression: a model to understand neural plasticity. NIDA Res Monogr 126:98-112.
10. Davidson BL, Breakefield XO. 2003. Viral vectors for gene delivery to the nervous system. Nat Rev Neurosci 4:353-364.
11. De Palma M, Venneri MA, Naldini L. 2003. In vivo targeting of tumor endothelial cells by systemic delivery of lentiviral vectors. Hum Gene Ther 14:1193-1206.
12. Deglon N, Hantraye P. 2005. Viral vectors as tools to model and treat neurodegenerative disorders. J Gene Med 7:530-539.
13. Dittgen T, Nimmerjahn A, Komai S, Licznerski P, Waters J, Margrie TW, Helmchen F, Denk W, Brecht M, Osten P. 2004. Lentivirus-based genetic manipulations of cortical neurons and their optical and electrophysiological monitoring in vivo. Proc Natl Acad Sci U S A 101:18206-18211.
14. Donovan DM, Takemura M, O'Hara BF, Brannock MT, Uhl GR. 1992. Preproenkephalin promoter "cassette" confers brain expression and synaptic regulation in transgenic mice. Proc Natl Acad Sci U S A 89:2345-2349.
15. Fallon J, Reid S, Kinyamu R, Opole I, Opole R, Baratta J, Korc M, Endo TL, Duong A, Nguyen G, Karkehabadhi M, Twardzik D, Patel S, Loughlin S. 2000. In vivo induction of massive proliferation, directed migration, and differentiation of neural cells in the adult mammalian brain. Proc Natl Acad Sci U S A 97:14686-14691.
16. Follenzi A, Ailles LE, Bakovic S, Geuna M, Naldini L. 2000. Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences. Nat Genet 25:217-222.
17. Follenzi A, Battaglia M, Lombardo A, Annoni A, Roncarolo MG, Naldini L. 2004. Targeting lentiviral vector expression to hepatocytes limits transgene-specific immune response and establishes long-term expression of human antihemophilic factor IX in mice. Blood 103:3700-3709.
18. Georgievska B, Jakobsson J, Persson E, Ericson C, Kirik D, Lundberg C. 2004. Regulated delivery of glial cell line-derived neurotrophic factor into rat striatum, using a tetracycline-dependent lentiviral vector. Hum Gene Ther 15:934-944.
19. Hyman SE, Konradi C, Kobierski L, Cole R, Senatus P, Green D. 1994. Pharmacologic regulation of striatal proenkephalin gene expression via transcription factor CREB. Prog Clin Biol Res 390:155-171.
20. Jakobsson J, Ericson C, Jansson M, Bjork E, Lundberg C. 2003. Targeted transgene expression in rat brain using lentiviral vectors. J Neurosci Res 73:876-885.
21. Jakobsson J, Georgievska B, Ericson C, Lundberg C. 2004. Lesion-dependent regulation of transgene expression in the rat brain using a human glial fibrillary acidic protein-lentiviral vector. Eur J Neurosci 19:761-765.
22. Joshi J, Sabol SL. 1991. Proenkephalin gene expression in C6 rat glioma cells: potentiation of cyclic adenosine 3′,5′-monophosphate- dependent transcription by glucocorticoids. Mol Endocrinol 5:1069-1080.
23. Kaplitt MG, Kwong AD, Kleopoulos SP, Mobbs CV, Rabkin SD, Pfaff DW. 1994. Preproenkephalin promoter yields region-specific and long-term expression in adult brain after direct in vivo gene transfer via a defective herpes simplex viral vector. Proc Natl Acad Sci U S A 91:8979-8983.
24. Le Y, Gagneten S, Larson T, Santha E, Dobi A, v. Agoston D, Sauer B. 2003. Far-upstream elements are dispensable for tissue-specific proenkephalin expression using a Cre-mediated knock-in strategy. J Neurochem 84:689-697.
25. Loughlin SE, Leslie FM, Fallon JH. 1995. Endogenous opioid systems. In: Paxinos G, editor. The rat nervous system. San Diego: Academic Press, p 975-1001.
26. Messing A, Brenner M. 2003. GFAP: functional implications gleaned from studies of genetically engineered mice. Glia 43:87-90.
27. Mitchell RS, Beitzel BF, Schroder AR, Shinn P, Chen H, Berry CC, Ecker JR, Bushman FD. 2004. Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences. PLoS Biol. 2:E234.
28. Steiner H, Gerfen CR. 1998. Role of dynorphin and enkephalin in the regulation of striatal output pathways and behavior. Exp Brain Res 123:60-76.
29. Su M, Hu H, Lee Y, d'Azzo A, Messing A, Brenner M. 2004. Expression specificity of GFAP transgenes. Neurochem Res 29:2075-2093.
30. Agoston D, Santha E, Shieh G, Lala R, Dobi A. 1998. Isolation and structural and genetic analysis of the mouse enkephalin gene and its d(AC/TG)n repeats. DNA Seq 9:217-226.
31. Weber W, Fussenegger M. 2004. Approaches for trigger-inducible viral transgene regulation in gene-based tissue engineering. Curr Opin Biotechnol 15:383-391.
32. West MJ, Slomianka L, Gundersen HJ. 1991. Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator. Anat Rec 231:482-497.
33. Zufferey R, Nagy D, Mandel RJ, Naldini L, Trono D. 1997. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat Biotechnol 15:871-875.
34. Zufferey R, Dull T, Mandel RJ, Bukovsky A, Quiroz D, Naldini L, Trono D. 1998. Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J Virol 72:9873-9880.
35. Zufferey R, Donello JE, Trono D, Hope TJ. 1999. Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors. J Virol 73:2886-2892.